| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,302 | 7,684 | 10,296 | 10,991 | | Cost of Revenue | 4,598 | 4,215 | 4,081 | 15,271 | | | Gross Profit | 2,704 | 3,469 | 6,215 | (4,280) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 521 | 472 | 451 | (9,871) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,553 | 3,547 | 3,326 | 3,571 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,370) | (550) | 2,438 | 2,020 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11) | (28) | (21) | (129) | | Earnings Before Interest And Taxes | (1,337) | 374 | 1,526 | (37) | | Interest Expense | 175 | 150 | 120 | 106 | | Income Before Tax | (1,617) | 224 | 1,406 | (143) | | Income Tax Expense | (642) | (284) | 919 | 345 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (877) | (411) | 1,406 | 1,588 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 997 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (877) | (411) | 1,406 | 2,585 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($877) | ($411) | $1,406 | $2,585 |
|
0.51% Nasdaq 
0.04 (0.12%) 
Income Statement
